Detection of PDGFRA mutations at exons 12 and 18 among chronic myeloid leukemia patients treated with imatinib mesylate

Imatinib mesylate (IM) resistance is an emerging and major challenge in the treatment of patients with chronic myeloid leukaemia (CML). Resistance toward IM can be divided into BCR-ABL dependent pathways and BCR-ABL independent pathway. In this study, the BCRABL independent pathway was investigated;...

Description complète

Détails bibliographiques
Auteur principal: Razali, Ruzi Hamimi
Format: Thèse
Langue:anglais
Publié: 2015
Sujets:
Accès en ligne:http://eprints.usm.my/39897/
Abstract Abstract here

Documents similaires